Clinical Trials Browser

Maintenance × Dermatologic × Clear all

NCT06587451 2026-02-24

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

Phase 3 Terminated

Melanoma

NCT02296398 2016-03-11

Long-term Use of Romidepsin in Patients With CTCL

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous